ReviewJournal of gastrointestinal cancer2026

Neoadjuvant and Perioperative Immunotherapy for Resectable Esophageal Squamous Cell Carcinoma: Current Evidence, Endpoints, and Clinical Integration.

Tamotsu Sagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.